Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies

BACKGROUND: Molecular markers that can discriminate indolent cancers from aggressive ones may improve the management of prostate cancer and minimize unnecessary treatment. Aberrant DNA methylation is a common epigenetic event in cancers and HOXD3 promoter hypermethylation (H3PH) has been found in pr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Prostate
Glavni autori: Chen, Leonard N, Rubin, Rachel S, Othepa, Eugide, Cer, Caroline, Yun, Elizabeth, Agarwal, Raghunath P, Collins, Brian T, McGeagh, Kevin, Pahira, John, Bandi, Guarav, Kowalczyk, Keith, Kumar, Deepak, Dritschilo, Anatoly, Collins, Sean P, Bostwick, David G, Lynch, John H, Suy, Simeng
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285328/
https://ncbi.nlm.nih.gov/pubmed/24847526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22790
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items